Geneos Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-400
| Closed | -$7.42K | – | 2203 |
|
|
2023
Q3 | $7.42K | Hold |
400
| – | – | ﹤0.01% | 1642 |
|
|
2023
Q2 | $4.42K | Hold |
400
| – | – | ﹤0.01% | 1769 |
|
|
2023
Q1 | $5.37K | Hold |
400
| – | – | ﹤0.01% | 1705 |
|
|
2022
Q4 | $4.95K | Hold |
400
| – | – | ﹤0.01% | 1704 |
|
|
2022
Q3 | $5K | Hold |
400
| – | – | ﹤0.01% | 1713 |
|
|
2022
Q2 | $5K | Hold |
400
| – | – | ﹤0.01% | 2223 |
|
|
2022
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 2305 |
|
|
2021
Q4 | $6K | Hold |
400
| – | – | ﹤0.01% | 2384 |
|
|
2021
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 2421 |
|
|
2021
Q2 | $7K | Hold |
400
| – | – | ﹤0.01% | 2356 |
|
|
2021
Q1 | $7K | Hold |
400
| – | – | ﹤0.01% | 2563 |
|
|
2020
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 2278 |
|
|
2020
Q3 | $16K | Hold |
400
| – | – | ﹤0.01% | 1775 |
|
|
2020
Q2 | $30K | Hold |
400
| – | – | ﹤0.01% | 1446 |
|
|
2020
Q1 | $26K | Hold |
400
| – | – | ﹤0.01% | 1407 |
|
|
2019
Q4 | $49K | Hold |
400
| – | – | ﹤0.01% | 1275 |
|
|
2019
Q3 | $25K | Hold |
400
| – | – | ﹤0.01% | 1518 |
|
|
2019
Q2 | $31K | Hold |
400
| – | – | ﹤0.01% | 1426 |
|
|
2019
Q1 | $44K | Sell |
400
-200
| -33% | -$21.9K | ﹤0.01% | 1213 |
|
|
2018
Q4 | $56K | Buy |
600
+100
| +20% | +$10.4K | ﹤0.01% | 1043 |
|
|
2018
Q3 | $63K | Buy |
500
+100
| +25% | +$10.6K | ﹤0.01% | 1064 |
|
|
2018
Q2 | $33K | Hold |
400
| – | – | ﹤0.01% | 1246 |
|
|
2018
Q1 | $24K | Hold |
400
| – | – | ﹤0.01% | 1322 |
|
|
2017
Q4 | $23K | Hold |
400
| – | – | ﹤0.01% | 1336 |
|
|
2017
Q3 | $23K | Buy |
+400
| New | +$43.1K | ﹤0.01% | 1274 |
|
Geneos Wealth Management's ICPT Position: Q4 2023 in Review
Geneos Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 400 shares — an estimated $7.42K sold.
Geneos Wealth Management first reported a position in ICPT in Q3 2017 and held it in 25 quarters. The position peaked at $63K in Q3 2018. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Geneos Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Geneos Wealth Management sold 400 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $7.42K.
- Geneos Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 25 quarters.
- Geneos Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $63K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.